Brainsway Operating Income Over Time
| BWAY Stock | USD 21.62 0.69 3.30% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Brainsway Performance and Brainsway Correlation. Brainsway | Build AI portfolio with Brainsway Stock |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainsway. Projected growth potential of Brainsway fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Brainsway assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 1 | Earnings Share 0.32 | Revenue Per Share | Quarterly Revenue Growth 0.287 | Return On Assets |
The market value of Brainsway is measured differently than its book value, which is the value of Brainsway that is recorded on the company's balance sheet. Investors also form their own opinion of Brainsway's value that differs from its market value or its book value, called intrinsic value, which is Brainsway's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainsway's market value can be influenced by many factors that don't directly affect Brainsway's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Brainsway's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Brainsway should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Brainsway's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Operating Income Analysis
Compare Brainsway and related stocks such as Neuropace, Delcath Systems, and Tactile Systems Tech Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NPCE | (22 M) | (22 M) | (22 M) | (22 M) | (22 M) | (22 M) | (22 M) | (22 M) | (22 M) | (22 M) | (13.1 M) | (23.7 M) | (40.8 M) | (27.2 M) | (21.7 M) | (19.5 M) | (20.5 M) |
| DCTH | (2.1 M) | (46.5 M) | (53.9 M) | (33 M) | (19.3 M) | (15.2 M) | (16.4 M) | (18.2 M) | (27.1 M) | (19.9 M) | (21.3 M) | (24.5 M) | (33.9 M) | (38.2 M) | (12.4 M) | (11.2 M) | (11.7 M) |
| TCMD | 2.4 M | 2.4 M | 2.4 M | 2.4 M | 3.8 M | 3.5 M | 4.3 M | 3.9 M | 3 M | 10.5 M | (3.6 M) | (1.8 M) | (12.8 M) | 18 M | 22.2 M | 25.5 M | 26.8 M |
| CERS | (15.9 M) | (15.9 M) | (17.3 M) | (28.3 M) | (44.3 M) | (61.1 M) | (61.4 M) | (57.5 M) | (55 M) | (66.2 M) | (58.3 M) | (48.9 M) | (34.1 M) | (30.1 M) | (14.2 M) | (12.8 M) | (13.4 M) |
| MASS | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (12.1 M) | (5.8 M) | (22.1 M) | (35.4 M) | (42.8 M) | (76.7 M) | (69 M) | (65.6 M) |
| SENS | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.7 M) | (28.8 M) | (42.4 M) | (56.3 M) | (87.6 M) | (130.7 M) | (79.1 M) | (57.2 M) | (68.6 M) | (75.6 M) | (74.8 M) | (67.4 M) | (70.7 M) |
| RXST | (46.1 M) | (46.1 M) | (46.1 M) | (46.1 M) | (46.1 M) | (46.1 M) | (46.1 M) | (46.1 M) | (46.1 M) | (46.1 M) | (35.4 M) | (52.8 M) | (63.3 M) | (50.1 M) | (36.9 M) | (33.2 M) | (34.8 M) |
| CVRX | (10.2 M) | (10.2 M) | (10.2 M) | (10.2 M) | (10.2 M) | (10.2 M) | (10.2 M) | (10.2 M) | (10.2 M) | (10.2 M) | (11.5 M) | (26 M) | (42.5 M) | (43.1 M) | (59.5 M) | (53.5 M) | (50.9 M) |
| SGHT | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (24 M) | (32.2 M) | (51.5 M) | (84 M) | (57.3 M) | (50.5 M) | (45.5 M) | (47.8 M) |
| VMD | 9.5 M | 9.5 M | 9.5 M | 9.5 M | 9.5 M | 10 M | 383 K | 8.8 M | 17 M | 8.9 M | 26.8 M | 11.6 M | 8.3 M | 14.3 M | 17.9 M | 20.6 M | 13.3 M |
Brainsway and related stocks such as Neuropace, Delcath Systems, and Tactile Systems Tech Operating Income description
Operating Income is the amount of profit realized from Brainsway operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Brainsway is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Brainsway | BWAY |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 16 Hartum St, |
| Exchange | NASDAQ Exchange |
USD 21.62
Additional Tools for Brainsway Stock Analysis
When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.